DRD2 and Parkinson disease: Some authors[39] evaluated a multidimensional statistical approach of both 123I-ioflupane SPECT and 123I-MIBG cardiac scintigraphy; they also studied 123I-labeled dopamine D2 receptor ligands (IBZM) in the differential diagnosis of both PD and other atypical parkinsonism.